Category: News

Update: ODYSSEY Outcomes

Update on ODYSSEY Outcomes – by Dr. Rajesh Dave, MD, FSCAI, FACC ODYSSEY Outcomes, the second of the cardiovascular outcomes studies with a PCSK9 inhibitor, this time in an acute

Management of ACS in the Elderly

by Ramesh Daggubati, MD With baby boomers living longer, a day does not pass without a physician wondering how to manage acute coronary syndrome in the elderly. Randomized controlled trials

New in Endovascular Thrombectomy for Stroke

AHA/ASA expands treatment window for percutaneous thrombectomy window to 24 hours in a newly released guideline at International Stroke Conference. The recommendation was based on DAWN & DEFUSE 3 trials.